Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;62(4):644-654.
doi: 10.1007/s00125-018-4805-x. Epub 2019 Jan 23.

The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes

Ming-Feng Xia  1   2 , Huan-Dong Lin  1   2 , Ling-Yan Chen  3 , Li Wu  1   2 , Hui Ma  3 , Qian Li  1   2 , Qiqige Aleteng  1   2 , Yu Hu  3 , Wan-Yuan He  4 , Jian Gao  5   6 , Hua Bian  1   2 , Xiao-Ying Li  1   2 , Xin Gao  7   8
Affiliations

The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes

Ming-Feng Xia et al. Diabetologia. 2019 Apr.

Abstract

Aims/hypothesis: The rs738409 C>G variant of the patatin-like phospholipase domain containing 3 gene (PNPLA3) increases the risk of non-alcoholic fatty liver disease (NAFLD) with no predisposition for insulin resistance. In this study, we aimed to investigate the influence of PNPLA3 polymorphisms on liver fat content (LFC) and glucose metabolic variables, and the associations between these, during the natural course of body weight changes in a Chinese adult cohort.

Methods: The LFC, measured using a quantitative ultrasound method, was prospectively monitored in 2189 middle-aged and elderly adults from the Shanghai Changfeng Study, together with changes in body weight and metabolic variables. General linear models were used to detect interactive effects between the PNPLA3 rs738409 genotype and 4 year changes in body weight on liver steatosis and glucose metabolism.

Results: The PNPLA3 homozygous GG genotype dissociated the changes in the LFC and OGTT 2 h post-load blood glucose (PBG) in relation to 4 year changes in body weight. PNPLA3 GG genotype carriers showed greater increases in the LFC and serum alanine aminotransferase (ALT) but lower PBG elevation and incident diabetes than PNPLA3 wild-type (CC) genotype carriers exhibiting the same degree of body weight increase. The interactions between the PNPLA3 genotype and changes in body weight on the LFC (false discovery rate [FDR]-adjusted pinteraction = 0.044) and ALT (FDR-adjusted pinteraction = 0.044) were significant. Subgroup analyses showed that the effect of the PNPLA3 GG genotype on changes in the LFC and PBG was only observed in metabolically unhealthy participants with insulin resistance or abdominal obesity.

Conclusions/interpretation: The PNPLA3 GG genotype interacted with changes in body weight to aggravate liver steatosis but reduced the risk of incident type 2 diabetes in metabolically unhealthy participants.

Keywords: Body weight; Diabetes; Gene–environment interaction; NAFLD; PNPLA3 gene variant.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Int J Obes (Lond). 2016 Jan;40(1):51-7 - PubMed
    1. Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846 - PubMed
    1. Obesity (Silver Spring). 2012 Feb;20(2):444-52 - PubMed
    1. Liver Int. 2015 Dec;35(12):2537-46 - PubMed
    1. Diabetes Care. 2018 Jan;41(Suppl 1):S51-S54 - PubMed

Publication types

MeSH terms

LinkOut - more resources